X-Ray-Controlled Generation of Peroxynitrite Based on Nanosized LiLuF<sub>4</sub> :Ce<sup>3+</sup> Scintillators and their Applications for Radiosensitization.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30260520.
- Also identified by DOI 10.1002/adma.201804046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Peroxynitrite (ONOO<sup>-</sup> ), the reaction product derived from nitric oxide (NO) and superoxide (O<sub>2</sub> <sup>-•</sup> ), is a potent oxidizing and nitrating agent that modulates complex biological processes and promotes cell death. Therefore, it can be expected that the overproduction of ONOO<sup>-</sup> in tumors can be an efficient approach in cancer therapy. Herein, a multifunctional X-ray-controlled ONOO<sup>-</sup> generation platform based on scintillating nanoparticles (SCNPs) and UV-responsive NO donors Roussin's black salt is reported, and consequently the mechanism of their application in enhanced therapeutic efficacy of radiotherapy is illustrated. Attributed to the radioluminescence and high X-ray-absorbing property of SCNPs, the nanocomposite can produce NO and O<sub>2</sub> <sup>-•</sup> simultaneously when excited by X-ray irradiation. Such simultaneous release of NO and O<sub>2</sub> <sup>-•</sup> ensures the efficient X-ray-controlled generation of ONOO<sup>-</sup> in tumors. Meanwhile, the application of X-rays as the excitation source can achieve better penetration depth and induce radiotherapy in this nanotherapeutic platform. It is found that the X-ray-controlled ONOO<sup>-</sup> -generation platform can efficiently improve the radiotherapy efficiency via directly damaging DNA, downregulating the expression of the DNA-repair enzyme, and overcoming the hypoxia-associated resistance in radiotherapy. Therefore, this SCNP-based platform may provide a new combinatorial strategy of ONOO<sup>-</sup> and radiotherapy to improve cancer treatment.
Medical subject headings
- Lithium Compounds
- Nanocomposites
- Neoplasms
- Peroxynitrous Acid
- Radiation-Sensitizing Agents
- X-Rays